Medical Gobbledygook Interpretation Help

Technique: Pre and postcontrast MR images of both breasts were submitted.

Findings: The breasts are composed of scattered areas of fibroglandular density, showing mild background parenchymal enhancement.

Left breast: Focal susceptibility artifact in the left breast upper inner quadrant, 11:00 axis, middle depth, denoting site of biopsy-proven invasive lobular carcinoma and lobular carcinoma in situ. Extending posteriorly to the biopsy marker there is focal nonmass enhancement, measuring 1.3 x 1.2 x 1.5 cm (T x AP x CC) (axial image 62, series 100; sagittal image 80, series 105) and extending anteriorly to the biopsy marker, there is a 2.0 cm postbiopsy hematoma with peripheral enhancement. In the left breast there are 2 additional minute enhancing masses, one of them slightly irregular with partially indistinct margins at 1:00 axis, middle depth, approximately 1.5 cm inferolateral to the index lesion, measuring 1.0 x 0.6 x 0.6 cm (axial image 57, series 100; sagittal image 58, series 105) the other oval circumscribed in the retroareolar area, anterior/middle depth, approximately 2.5 cm inferolateral to the index lesion, measuring 0.4 x 0.3 x 0.3 cm (axial image 47, series 100; sagittal image 69,series 105), without STIR hyperintense correlates. Benign-appearing intramammary lymph node in the left lower outer quadrant, posterior depth.

• Focal non mass in segment measuring up to 1.5 cm at site of biopsy-proven invasive lobular carcinoma and lobular carcinoma in situ in the left breast 11:00 axis (extending posteriorly to the biopsy marker).
• §There are 2 additional indeterminate subcentimeter masses in the left 1:00 axis and retroareolar area, for which MRI guided biopsy is recommended, since this masses may be difficult to identify on an ultrasound.